Healthy Extracts (HYEX) Other Non-Current Liabilities (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Other Non-Current Liabilities came in at $352411.0 in Q4 2025, down 43.65% year-on-year from $625420.0 in Q4 2024, and down 36.84% quarter-over-quarter from $557997.0 in Q3 2025.
Healthy Extracts (HYEX) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends
Healthy Extracts' Other Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $352411.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 43.65% year-over-year to $352411.0 in Q4 2025; TTM through Dec 2025 was $352411.0, a 43.65% decrease from a year earlier, with the FY2025 full-year figure at $352411.0, down 43.65% from the prior year.
- Other Non-Current Liabilities eased to $352411.0 in Q4 2025 per HYEX's latest filing, from $557997.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.3 million in Q3 2021 and bottomed at $13549.0 in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $389998.5 (2024), against an average of $481718.7.
- Across the five-year window, Other Non-Current Liabilities surged 12500.18% in 2021 and tumbled 98.06% in 2022, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $92527.0 in 2021, then soared by 66.6% to $154150.0 in 2022, then changed by 0.0% to $154150.0 in 2023, then surged by 305.72% to $625420.0 in 2024, then sank by 43.65% to $352411.0 in 2025.
- Per Business Quant, the three latest HYEX Other Non-Current Liabilities figures stand at $352411.0 (Q4 2025), $557997.0 (Q3 2025), and $678888.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 352,411.00 |
| Sep 30, 2025 | 557,997.00 |
| Jun 30, 2025 | 678,888.00 |
| Mar 31, 2025 | 880,874.00 |
| Dec 31, 2024 | 625,420.00 |
| Sep 30, 2024 | 427,586.00 |
| Jun 30, 2024 | 736,623.00 |
| Mar 31, 2024 | 910,779.00 |
| Dec 31, 2023 | 154,150.00 |
| Sep 30, 2023 | 135,698.00 |
| Jun 30, 2023 | 173,069.00 |
| Mar 31, 2023 | 186,919.00 |
| Dec 31, 2022 | 154,150.00 |
| Sep 30, 2022 | 338,787.00 |
| Jun 30, 2022 | 234,365.00 |
| Mar 31, 2022 | 13,549.00 |
| Dec 31, 2021 | 92,527.00 |
| Sep 30, 2021 | 1.30 Mn |
| Jun 30, 2021 | 987,427.00 |
| Mar 31, 2021 | 697,982.00 |